Cosmos Health (COSM) Equity Income (2025 - 2026)
Cosmos Health's (COSM) quarterly Equity Income came in at $3650.0 in Q2 2026, up 38.31% on a YoY basis from $2639.0 in Q2 2025, and up 38.31% quarter-over-quarter from $2639.0 in Q2 2025.
Powered by 
Analysis
Cosmos Health (COSM) Equity Income (2025 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Equity Income for 2 consecutive years, with $3650.0 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -500,000.00 |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -84,502.07 |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 3,650.00 |